ArticleOncogene2020
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
Susumu Kohno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncogene2020
Susumu Kohno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.